253 related articles for article (PubMed ID: 21932384)
41. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
42. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
43. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
Shehata MA; Abou El-Enein A; El-Sharnouby GA
Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
[TBL] [Abstract][Full Text] [Related]
44. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis.
Kikuchi K; Lian ZX; Yang GX; Ansari AA; Ikehara S; Kaplan M; Miyakawa H; Coppel RL; Gershwin ME
Gastroenterology; 2005 Feb; 128(2):304-12. PubMed ID: 15685542
[TBL] [Abstract][Full Text] [Related]
45. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
46. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
47. Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.
Liu CJ; Chen PJ; Shau WY; Kao JH; Lai MY; Chen DS
Liver Int; 2003 Jun; 23(3):148-55. PubMed ID: 12955877
[TBL] [Abstract][Full Text] [Related]
48. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study.
Goritsas CP; Athanasiadou A; Arvaniti A; Lampropoulou-Karatza C
J Clin Gastroenterol; 1995 Apr; 20(3):220-4. PubMed ID: 7797831
[TBL] [Abstract][Full Text] [Related]
49. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].
Li HK; Qin Y; Li XM; Li Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):426-8. PubMed ID: 19567020
[TBL] [Abstract][Full Text] [Related]
50. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
51. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients.
Rodríguez-Bayona B; Ramos-Amaya A; Pérez-Venegas JJ; Rodríguez C; Brieva JA
Arthritis Res Ther; 2010; 12(3):R108. PubMed ID: 20525218
[TBL] [Abstract][Full Text] [Related]
52. Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.
Manzoor S; Idrees M; Ashraf J; Mehmood A; Butt S; Fatima K; Akbar H; Rehaman IU; Qadri I
Virol J; 2011 Sep; 8():431. PubMed ID: 21899776
[TBL] [Abstract][Full Text] [Related]
53. HCV genotypes in patients with liver disease of different stages and severity.
Mangia A; Cascavilla I; Lezzi G; Spirito F; Maertens G; Parlatore L; Saracco G; Rizzetto M; Andriulli A
J Hepatol; 1997 Jun; 26(6):1173-8. PubMed ID: 9210601
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
[TBL] [Abstract][Full Text] [Related]
56. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.
Ni J; Hembrador E; Di Bisceglie AM; Jacobson IM; Talal AH; Butera D; Rice CM; Chambers TJ; Dustin LB
J Immunol; 2003 Mar; 170(6):3429-39. PubMed ID: 12626604
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Mohamed AA; Omran D; El-Feky S; Darwish H; Kassas A; Farouk A; Ezzat O; Abdo SM; Zahran FE; El-Demery A; Omran MM
Br J Biomed Sci; 2021 Jan; 78(1):18-22. PubMed ID: 32573389
[TBL] [Abstract][Full Text] [Related]
59. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients.
Farid RM; Abu-Zeid RM; El-Tawil A
Int J Clin Exp Pathol; 2014; 7(5):2707-17. PubMed ID: 24966992
[TBL] [Abstract][Full Text] [Related]
60. Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.
Plissonnier ML; Lahlali T; Michelet M; Lebossé F; Cottarel J; Beer M; Neveu G; Durantel D; Bartosch B; Accardi R; Clément S; Paradisi A; Devouassoux-Shisheboran M; Einav S; Mehlen P; Zoulim F; Parent R
PLoS Biol; 2016 Mar; 14(3):e1002421. PubMed ID: 27031829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]